Author:
Wallemacq P. E.,Furlan V.,Möller A.,Schäfer A.,Stadler P.,Firdaous I.,Taburet A -M.,Reding R.,De Clety S. Clement,De Ville De Goyet J.,Sokal E.,Lykavieris L.,Van Leeuw V.,Bernard O.,Otte J. B.,Undre N. A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference10 articles.
1. Tzakis A.G., Reyes J., Todo S. et al. (1993): Two-year experience with FK 506 in pediatric patients. Transplant. Proc., 25, 619–621.
2. Inomata Y., Tanaka K., Egawa H. et al. (1996): The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation, 61, 247–252.
3. Tzakis A.G., Reyes J., Todo S. et al. (1991): FK 506 versus cyclosporine in pediatric liver transplantation. Transplant. Proc., 23, 3010–3015.
4. McDiarmid S.V., Busuttil R.W., Ascher N.L. et al. (1995): FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the US multicenter trial. Transplantation, 59, 530–536.
5. Lee C., Jusko W., Shaefer M. et al. (1993): Pharmacokinetics of tacrolimus FK506 in transplant patients. Clin. Pharmacol. Ther., 53, 181.
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献